We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
-8.2%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$462M
AUM Growth
-$51.6M
Cap. Flow
-$441K
Cap. Flow %
-0.1%
Top 10 Hldgs %
15.6%
Holding
395
New
18
Increased
8
Reduced
14
Closed
13

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.31M
2
ABBV icon
AbbVie
ABBV
+$1.95M
3
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$1.27M
4
GERN icon
Geron
GERN
+$1.18M
5
KHC icon
Kraft Heinz
KHC
+$1.16M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.93M
2
AMAG
AMAG Pharmaceuticals
AMAG
+$1.86M
3
AEC
ASSOCIATED ESTATES REALTY CORP
AEC
+$1.72M
4
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$1.3M
5
PLL
PALL CORP
PLL
+$1.25M

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Financials 14.94%
3 Healthcare 14.92%
4 Industrials 11.55%
5 Consumer Staples 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GEN icon
251
Gen Digital
GEN
$16.4B
$584K 0.13%
30,000
– –
NTGR icon
252
NETGEAR
NTGR
$648M
$583K 0.13%
20,000
– –
INVX
253
Innovex International
INVX
$1.96B
$582K 0.13%
10,000
– –
SE
254
DELISTED
Spectra Energy Corp Wi
SE
$581K 0.13%
22,100
– –
FINL
255
DELISTED
Finish Line
FINL
$579K 0.13%
30,000
– –
XEL icon
256
Xcel Energy
XEL
$48.8B
$575K 0.12%
16,243
– –
GCO icon
257
Genesco
GCO
$425M
$571K 0.12%
10,000
– –
LGND icon
258
Ligand Pharmaceuticals
LGND
$5.76B
$571K 0.12%
10,686
– –
LUV icon
259
Southwest Airlines
LUV
$22B
$571K 0.12%
15,000
– –
AVY icon
260
Avery Dennison
AVY
$13B
$566K 0.12%
10,000
– –
VRNT
261
DELISTED
Verint Systems
VRNT
$560K 0.12%
25,482
– –
MTH icon
262
Meritage Homes
MTH
$4.58B
$548K 0.12%
30,000
– –
TBPH icon
263
Theravance Biopharma
TBPH
$874M
$541K 0.12%
49,284
+35,000
+245% +$446K
HAL icon
264
Halliburton
HAL
$26.9B
$540K 0.12%
15,267
– –
SWKS icon
265
Skyworks Solutions
SWKS
$9.37B
$532K 0.12%
6,318
– –
FARO
266
DELISTED
Faro Technologies
FARO
$525K 0.11%
15,000
– –
ACM icon
267
Aecom
ACM
$9.3B
$519K 0.11%
18,879
– –
EMN icon
268
Eastman Chemical
EMN
$8B
$518K 0.11%
8,000
– –
LUMN icon
269
Lumen
LUMN
$6.57B
$516K 0.11%
20,550
– –
NPKI
270
NPK International
NPKI
$1.06B
$512K 0.11%
100,000
– –
CVLT icon
271
Commault Systems
CVLT
$4.88B
$509K 0.11%
15,000
– –
HES
272
DELISTED
Hess
HES
$501K 0.11%
10,000
– –
KMT icon
273
Kennametal
KMT
$2.59B
$498K 0.11%
20,000
– –
SNPS icon
274
Synopsys
SNPS
$74.4B
$496K 0.11%
10,742
– –
PH icon
275
Parker-Hannifin
PH
$123B
$487K 0.11%
5,000
– –
9 10
11
12 13

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q3 2015 Portfolio in Review

As of Q3 2015, NJ State Employees Deferred Compensation Plan held 395 positions worth $462M, down 10% from $514M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

NJ State Employees Deferred Compensation Plan's Q3 2015 filing shows 18 new, 8 increased, 14 reduced and 13 closed positions. Its largest new stake was Biogen: 7,000 shares worth $2.04M. The largest sale was Johnson & Johnson, an estimated $1.93M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • NJ State Employees Deferred Compensation Plan's largest Q3 2015 buy was Biogen: 7,000 shares worth $2.04M.
  • NJ State Employees Deferred Compensation Plan added most to AbbVie in Q3 2015, an estimated $1.95M increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q3 2015 reduction was Johnson & Johnson, cutting an estimated $1.93M.
  • NJ State Employees Deferred Compensation Plan fully exited ASSOCIATED ESTATES REALTY CORP in Q3 2015, selling an estimated $1.72M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 16% of its $462M portfolio in Q3 2015.
  • NJ State Employees Deferred Compensation Plan opened 18 new positions and closed 13 in Q3 2015.
  • NJ State Employees Deferred Compensation Plan's portfolio value fell 10% quarter-over-quarter to $462M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2015, filed 2 Nov 2015.